Research graph
References from Nephrolithiasis in Cystic Fibrosis: A Gastrointestinal Perspective on Mechanisms and Management. Local targets link to admitted publications; unresolved targets remain external evidence.
Cystic Fibrosis
10.1056/nejmra043184 · 2005 · External reference
Cystic Fibrosis in the Intestine and the Influence on Digestion
10.29245/2578-3009/2020/3.1187 · 2020 · External reference
Cystic Fibrosis
10.1016/s0140-6736(16)00576-6 · 2016 · External reference
Standards for the Care of People With Cystic Fibrosis (CF); Recognising and Addressing CF Health Issues
10.1016/j.jcf.2024.01.005 · 2024 · External reference
Renal Diseases in Adults With Cystic Fibrosis: A 40 Year Single Centre Experience
10.1007/s40620-015-0179-z · 2015 · External reference
Long‐Term Effect of Chronic Intravenous and Inhaled Nephrotoxic Antibiotic Treatment on the Renal Function of Patients With Cystic Fibrosis
10.1111/j.1542-4758.2012.00675.x · 2012 · External reference
Cystic Fibrosis–Related Kidney Disease—Emerging Morbidity and Disease Modifier
10.1007/s00467-025-06715-3 · 2025 · External reference
Systematic Review of the Prevalence of Kidney Stones in Cystic Fibrosis
10.1089/end.2021.0151 · 2021 · External reference
Cystic Fibrosis From the Gastroenterologist's Perspective
2012 · External reference
The Roles and Mechanisms of Intestinal Oxalate Transport in Oxalate Homeostasis
10.1016/j.semnephrol.2008.01.007 · 2008 · External reference
Urinary Excretion Substances in Patients With Cystic Fibrosis: Risk of Urolithiasis?
10.1007/s004670050452 · 1998 · External reference
Evaluation and Medical Management of Kidney Stones in Children
10.1016/j.juro.2014.04.108 · 2014 · External reference
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART II
10.1016/j.juro.2016.05.091 · 2016 · External reference
Consensus Report on Nutrition for Pediatric Patients With Cystic Fibrosis
2002 · External reference
ECFS Best Practice Guidelines: The 2018 Revision
10.1016/j.jcf.2018.02.006 · 2018 · External reference
Elevated Rates and Earlier Onset of Nonpulmonary Comorbidities in Adults With Cystic Fibrosis
10.1513/annalsats.202502-170oc · 2025 · External reference
Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor
10.1542/peds.2016-2522 · 2017 · External reference
Kidney Effects of Triple CFTR Modulator Therapy in People With Cystic Fibrosis
10.1093/ckj/sfae256 · 2024 · External reference
The Global, Regional, and National Burden of Urolithiasis in 204 Countries and Territories, 2000‐2021: A Systematic Analysis for the Global Burden of Disease Study 2021
10.1016/j.eclinm.2024.102924 · 2024 · External reference
The Association of Nephrolithiasis With Cystic Fibrosis
10.1016/s0272-6386(03)00403-7 · 2003 · External reference
Metabolic Risk Factors for Stone Formation in Cystic Fibrosis
10.1097/00005392-200202000-00007 · 2002 · External reference
Prevalence and Risk Factors for Nephrolithiasis in Adults With Cystic Fibrosis: A Retrospective Cohort Study
10.1371/journal.pone.0340293 · 2026 · External reference
Urinary Stone Disease Prevalence and Associations in Cystic Fibrosis
10.1007/s00240-021-01244-8 · 2021 · External reference
Unresolved reference
2024 · External reference
Unresolved reference
External reference
Evolution of Pancreatic Function During the First Year in Infants With Cystic Fibrosis
10.1016/j.jpeds.2012.10.008 · 2013 · External reference
Disparities in First Evaluation of Infants With Cystic Fibrosis Since Implementation of Newborn Screening
10.1016/j.jcf.2022.07.010 · 2023 · External reference
Urinary Tract Stones in Cystic Fibrosis
10.1016/j.prrv.2018.03.007 · 2018 · External reference
Urinary System Involvement in Children With Cystic Fibrosis: A Single‐Center Retrospective Cohort
10.1002/ppul.71551 · 2026 · External reference
The Global, Regional, and National Burden of Pediatric Stone Disease: 1990–2021 and Projections for the Next Two Decades
10.3389/fped.2025.1529407 · 2025 · External reference
Metabolic Evaluation and Disease Characteristics of Urolithiasis in Children From 2020 to 2024: a Retrospective Single‐Center Study at the National Children's Medical Center
10.1186/s12887-025-05773-8 · 2025 · External reference
Factors Increasing the Risk for Stone Formation in Adult Patients With Cystic Fibrosis
10.1093/ndt/gfl067 · 2006 · External reference
Which Factors Account for Renal Stone Formation in Cystic Fibrosis?
10.5414/cnp59160 · 2003 · External reference
Gout and Hyperuricaemia in Adults With Cystic Fibrosis
10.1258/jrsm.2011.s11106 · 2011 · External reference
Hyperuricosuria Due to High‐Dose Pancreatic Extract Therapy in Cystic Fibrosis
10.1056/nejm197607292950503 · 1976 · External reference
Uric Acid Serum Concentrations in CF‐Children After Pancreatic Enzyme Supplementation
1989 · External reference
Oxalate and Calcium Excretion in Cystic Fibrosis
10.1136/adc.83.3.244 · 2000 · External reference
Risk Factors for Small Bowel Bacterial Overgrowth in Cystic Fibrosis
10.1097/mpg.0b013e31802c0ceb · 2007 · External reference
Bacterial Overgrowth, Dysbiosis, Inflammation, and Dysmotility in the Cystic Fibrosis Intestine
10.1016/j.jcf.2017.07.014 · 2017 · External reference
Effect of Bile Salts and Fatty Acids on the Colonic Absorption of Oxalate
10.1016/s0016-5085(76)80318-6 · 1976 · External reference
Pathophysiology and Treatment of Enteric Hyperoxaluria
10.2215/cjn.08000520 · 2021 · External reference
Pathophysiology and Management of Enteric Hyperoxaluria
10.1016/j.clinre.2024.102322 · 2024 · External reference
Gut to Stone: The Woes of Malabsorption and Kidney Stone Growth
10.1016/j.ekir.2025.07.036 · 2025 · External reference
Kidney Stones are Common in Patients With Short‐Bowel Syndrome Receiving Long‐Term Parenteral Nutrition: A Predictive Model for Urolithiasis
10.1002/jpen.2133 · 2022 · External reference
Pancreatic Exocrine Insufficiency is a Risk Factor for Kidney Stones in Patients With Chronic Pancreatitis
10.1016/j.pan.2023.03.006 · 2023 · External reference
Association Between Chronic Pancreatitis and Urolithiasis: A Population‐Based Cohort Study
10.1371/journal.pone.0194019 · 2018 · External reference
Antibiotic Treatment‐Induced Tubular Dysfunction as a Risk Factor for Renal Stone Formation in Cystic Fibrosis
10.1067/mpd.2002.120694 · 2002 · External reference
Loss of Cystic Fibrosis Transmembrane Regulator Impairs Intestinal Oxalate Secretion
10.1681/asn.2016030279 · 2017 · External reference
Stone Composition, Metabolic Profile and the Presence of the Gut‐Inhabiting Bacterium Oxalobacter formigenes as Risk Factors for Renal Stone Formation
10.1159/000072285 · 2003 · External reference
Infrequency of Colonization With Oxalobacter Formigenes in Inflammatory Bowel Disease: Possible Role in Renal Stone Formation
10.1111/j.1440-1746.2004.03510.x · 2004 · External reference
Oxalobacter Formigenes Reduce the Risk of Kidney Stones in Patients Exposed to Oral Antibiotics: A Case–Control Study
10.1007/s11255-020-02627-3 · 2021 · External reference
Inducing Oxalobacter Formigenes Colonization Reduces Urinary Oxalate in Healthy Adults
10.1016/j.ekir.2025.02.004 · 2025 · External reference
Absence of Oxalobacter Formigenes in Cystic Fibrosis Patients: A Risk Factor for Hyperoxaluria
10.1016/s0140-6736(98)03038-4 · 1998 · External reference
10.5812/numonthly.105530
10.5812/numonthly.105530 · External reference
Absorptive Hyperoxaluria Leads to an Increased Risk for Urolithiasis or Nephrocalcinosis in Cystic Fibrosis
10.1053/j.ajkd.2005.06.003 · 2005 · External reference
Renal Impairment in Children With Cystic Fibrosis
10.1016/j.jcf.2010.03.006 · 2010 · External reference
Hypocitraturia: Its Importance as a Factor in the Development of Urolithiasis
2019 · External reference
Monogenic Causation of Pediatric Nephrolithiasis
10.3389/fruro.2022.1075711 · 2022 · External reference
Pediatric Stone Disease
10.1016/j.ucl.2023.04.009 · 2023 · External reference
Unresolved reference
2025 · External reference
Guideline of Guidelines for Kidney and Bladder Stones
10.5152/tud.2020.20315 · 2020 · External reference
Kidney Stone Disease: Risk Factors, Pathophysiology and Management
10.1038/s41581-025-00990-x · 2025 · External reference
Pediatric Nephrolithiasis
10.3390/healthcare11040552 · 2023 · External reference
Nutritional Challenges of Infants With Cystic Fibrosis
10.1016/s0378-3782(01)00206-7 · 2001 · External reference
ESPEN‐ESPGHAN‐ECFS Guideline on Nutrition Care for Cystic Fibrosis
10.1016/j.clnu.2023.12.017 · 2024 · External reference
Consensus Statement Addressing Controversies and Guidelines on Pediatric Urolithiasis
10.1007/s00345-024-05161-4 · 2024 · External reference
Diet and Alternative Therapies in the Management of Stone Disease
10.1016/j.ucl.2012.09.011 · 2013 · External reference
Effect of Dietary Oxalate and Calcium on Urinary Oxalate and Risk of Formation of Calcium Oxalate Kidney Stones
10.1016/0002-8223(93)91530-4 · 1993 · External reference
Medical Management of Kidney Stones: AUA Guideline
10.1016/j.juro.2014.05.006 · 2014 · External reference
A Phase 3 Open‐Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age With Cystic Fibrosis and at Least One F508del Allele
10.1164/rccm.202102-0509oc · 2021 · External reference
Calcium Intake and Urinary Stone Disease
2014 · External reference
Citrate and Renal Calculi
1986 · External reference
10.1002/14651858.cd004292.pub4
10.1002/14651858.cd004292.pub4 · External reference
10.1097/ju.0000000000005227
10.1097/ju.0000000000005227 · External reference
Metabolic Evaluation of First‐Time Uncomplicated Renal Stone Formers: A Prospective Study
10.1097/cu9.0000000000000169 · 2023 · External reference
Once‐Daily Versus Multiple‐Daily Dosing of Aminoglycosides in Cystic Fibrosis
2013 · External reference
ESPR Uroradiology Task Force and ESUR Paediatric Working Group: Imaging Recommendations in Paediatric Uroradiology, Part IV: Minutes of the ESPR Uroradiology Task Force Mini‐Symposium on Imaging in Childhood Renal Hypertension and Imaging of Renal Trauma in Children
10.1007/s00247-011-2089-0 · 2011 · External reference
Best Practice in Interventional Management of Urolithiasis: An Update From the European Association of Urology Guidelines Panel for Urolithiasis 2022
10.1016/j.euf.2022.06.014 · 2023 · External reference
Ureteroscopy vs Shockwave Lithotripsy to Remove Kidney Stones in Children and Adolescents: A Nonrandomized Clinical Trial
10.1001/jamanetworkopen.2025.25789 · 2025 · External reference
Between a Rock and an Airspace: Pneumothorax After Extracorporeal Shock Wave Lithotripsy for Renal Stones in a Patient With Cystic Fibrosis
10.1016/j.chest.2018.03.023 · 2018 · External reference
188: Cystic Fibrosis Kidney Stone Disease in the Era of CFTR Modulator Use and the COVID‐19 Pandemic
10.1016/s1569-1993(21)01613-1 · 2021 · External reference
Gut Microbiota Modulation via Fecal Microbiota Transplantation Mitigates Hyperoxaluria and Calcium Oxalate Crystal Depositions Induced by High Oxalate Diet
10.1080/19490976.2025.2457490 · 2025 · External reference
Human Fecal Microbiota Transplantation Attenuates High Dietary Oxalate‐Induced Renal Calcium Oxalate Crystal Depositions in Rats via Repairing Allobaculum‐Related Gut Barrier Damage
10.1128/msystems.00810-25 · 2025 · External reference
Unresolved reference
External reference
Randomized Placebo‐Controlled Trial of Reloxaliase in Enteric Hyperoxaluria
10.1056/evidoa2100053 · 2022 · External reference
Use of a Probioitic to Decrease Enteric Hyperoxaluria
10.1111/j.1523-1755.2005.00520.x · 2005 · External reference
Diagnosis and Emerging Biomarkers of Cystic Fibrosis‐Related Kidney Disease (CFKD)
10.3390/jcm14155585 · 2025 · External reference
